Trends in nanopharmaceutical patents

International Journal of Molecular Sciences

Volumn 14, Issue 4, 2013, Pages 7016-7031

  Antunes, Adelaide ^a,b   Fierro, Iolanda ^a   Guerrante, Rafaela ^a   Mendes, Flavia ^b   Alencar, Maria Simone de M ^c  

^a National Institute of Industrial Property (Brazil)   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Brazil   (Brazil)

Author keywords

Health; Nanotechnology; Patents; Pharmaceutical

Indexed keywords

ANTINEOPLASTIC AGENT; CARBON; CONTRAST MEDIUM; MONOCLONAL ANTIBODY; NANOFILM; NANOMATERIAL; NANOPARTICLE; NANOROD; NANOTUBE; PACLITAXEL; RAPAMYCIN; TAXANE DERIVATIVE;

ARTICLE; BLADDER CANCER; BREAST CANCER; COLON CANCER; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; DRUG DELIVERY SYSTEM; HUMAN; LUNG CANCER; MELANOMA; NANOBIOTECHNOLOGY; NANOPHARMACEUTICS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; PATENT; PROSTATE CANCER; TOXICITY; TREND STUDY; X RAY; DIAGNOSTIC IMAGING; NANOMEDICINE; NEOPLASMS; TOXICITY TESTING; TRENDS;

DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; HUMANS; NANOMEDICINE; NANOPARTICLES; NEOPLASMS; PATENTS AS TOPIC; TOXICITY TESTS;

EID: 84875449463     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14047016     Document Type: Article

References (48)

1. Seeking Alpha. DNA Nanotechnology: 3 Companies Building Better Synthetic Vaccines. Available online: http://seekingalpha.com/article/853551-dna-nanotechnology-3-companiesbuilding-better-synthetic-vaccines (accessed on 11 December 2012).
2. Sahoo, S.K.; Parveen, S.; Panda, J.J. The present and future of nanotechnology in human health care. Nanomedicine 2007, 3, 20-31.
3. The Freedonia Group. Nanotechnology in Health Care: US Industry Study with Forecasts to 2011, 2016 & 2021. Available online: http://www.freedoniagroup.com/brochure/21xx/2168smwe.pdf (accessed on 7 December 2012)
4. Alencar, M.S.M. Study of the Future through the Application of Technological Prospecting Techniques: The Case of Nanotechnology. Ph.D. Thesis, Federal University of Rio de Janeiro, November 2008.
5. Schmidt, S.R. Fusion-proteins as biopharmaceuticals-Applications and challenges. Curr. Opin. Drug Discov. Devel. 2009, 12, 284-295.
6. Alencar, M.S.M.; Porter, A.L.; Antunes, A.M.S. Nanopatenting patterns in relation to product life cycle. Technol. Forecast. Soc. Change 2007, 74, 1661-1680.
7. The Vantage Point. Privately owned software developed by the North American company; Search Technology, capable of importing and dealing with text and numeric data from data bases, and not just those related to patents. After establishing the required criteria, this software is capable of grouping the data obtained in pre-determined series, establishing correlations between them. Other benefits are the capacity to normalize data and generate reports with the results. Available online: http://www.thevantagepoint.com/ (accessed on 7 December 2012).
8. International Patent Classification. The IPC was established in 1975 introduced after the Strasbourg Accord and is run by the World Intellectual Property Organization (WIPO). The aim of this system is to make patent documents available in an organized and standardized way, to make the technological and legal information contained in them easily accessible (using search tools). The IPC is currently used by more than 100 countries and the updated version is available at the WIPO site. Available online: http://www.wipo.int/classifications/ipc/ (accessed on 7 December 2012).
9. Manual Code. Available online: http://ip-science.thomsonreuters.com/support/patents/dwpiref/ reftools/classification/mc-manuals (accessed on 17 September 2012).
10. Lucien, M.P.R.; Acar, H.; Bonitatatebus, P.J.J.; Dixon, W.T.; Kulkarni, A.M. Nanoparticles with inorganic core and methods of using them. U.S. Patent 2006/0018835, 26 January 2006.
11. Bonitatibus, P.J.; Butts, M.D.; Colborn, R.E.; Kulkarni, A.M.; Hay, B.A.; Torres, A.S.; Bales, B.C.; Marino, M.E. Nanoparticle Contrast Agents for Diagnostic Imaging. U.S. Patent 2010/278748, 4 November 2010.
12. Hay, B.A.; Bales, B.C.; Luttrell, M.T.; Kandapallil, B.I.I. Diagnostic Agent Composition and Associated Methods Thereof. U.S. Patent 2012/0156142, 21 June 2012.
13. Bonitatibus, P.J.; Butts, M.D.; Colborn, R.E.; Kulkarni, A.M.; Hay, B.A.; Torres, A.S.; Bales, B.C.; Marino, M.E. Nanoparticle Contrast Agents for Diagnostic Imaging. U.S. Patent 2010/278749, 4 November 2010.
14. Butts, M.D.; Colborn, R.E.; Bonitatibus, P.J.; Kulkarni, A.M.; Hay, B.A.; Torres, A.S.; Bales, B.C.; Marino, M.E. Nanoparticle Contrast Agents for Diagnostic Imaging. U.S. Patent 2010/166664, 7 July 2010.
15. Butts, M.D.; Colborn, R.E.; Bonitatibus, P.J.; Kulkarni, A.M.; Hay, B.A.; Torres, A.S.; Bales, B.C.; Marino, M.E. Nanoparticle Contrast Agents for Diagnostic Imaging. U.S. Patent 2010/166665, 7 July 2010.
16. Gu, F.X.; Teply, B.A.; Langer, R.S.; Farokhzad, O.C. Polymers for Functional Particles. WO2007133807, 22 November 2007.
17. Mirkin, C.A.; Giljohann, D.A.; Daniel, W.L.; Lippard, S.J.; Dhar, S. Polyvalent Polynucleotide Nanoparticle Conjugates as Delivery Vehicles for a Chemotherapeutic Agent. WO/2011/028847, 10 March 2011.
18. Cunningham, P.H.; Wood, K.G.; Langer, R.; Litlle, S. Hierarchically Self-assembling Linear-Dendritic Hybrid Polymers for Delivery of Biologically Active Agents. WO/2007/002663, 4 January 2007.
19. Capila, I.; Sengupta, S.; Zhao, G.; Eavarone, D.; Sasisekharan, R. Nanocell Drug Delivery System. WO/2008/014478, 31 January 2008.
20. Nguyen, D.; Anderson, D.G.; Langer, R.; Mahon, K.P. Modulation of the Immune Response. WO/2010/062322, 3 June 2010.
21. Desai, N.P.; Soon-Shiong, P. Methods and Compositions for Treating Pulmonary Hypertension. WO/2008/137148, 13 November 2008.
22. Desai, N.P.; Soon-Shiong, P., Trieu, V. Compositions and methods of delivery of pharmacological agents. U.S. Patent 2010/196490, 5 August 2010.
23. Trieu, V.; D'Cruz, O., Desai, N.P. Combinations and Modes of Administration of Therapeutic Agents and Combination Therapy. WO/2010/068925, 17 June 2010.
24. Liversidge, E.; Wei, L. Stabilization of Chemical Compounds Using Nanoparticulate Formulations. U.S. Patent 2007/224279, 27 September 2007.
25. Ryde, N.P.; Snyder, P.; Liu, W.; Slifer, D. Reduction of Flake-like Aggregation in Nanoparticulate Active Agent Compositions. WO/2010/138539, 2 December 2010.
26. Layre, A.M.; Gref, R.; Couvreur, P.; Richard, J. Nanoparticules Polymeriques Composites. France Patent 2872703, 13 January 2006.
27. Nel, A.E. Assessing the Toxic Potential of Nanomaterials. WO/2008/010843, 24 January 2008.
28. Chen, F.F., inventor. University of California, assignee. Size-dependent Biological Effect of Nanoparticles. WO/2009/002386, 31 December 2008.
29. Acar, H.Y.; Syud, F.A.; Garaas, R.N.; Bonitatebus, J.P.J.; Kulkarni, A.M. Contrast Agents for Magnetic Resonance Imaging. U.S. Patent 2005/260137, 24 November 2005.
30. Hurd, R.E. Magnetic Resonance Imaging (MRI) Agents: Water Soluble Carbon-13 Enriched Fullerene and Carbon Nanotubes for Use with Dynamic Nuclear Polarization. U.S. Patent 2007/025918, 1 February 2007.
31. Bonitatibus, P.J.; Axelsson, O.H.E.; Kulkarni, A.M.; Bales, B.C.; Walter, D.J.; Torres, A.S.; Treynor, C. Nanoparticle-based Imaging Agents for X-ray/Computed Tomography. U.S. Patent 2007/098640, 3 May 2007.
32. Weiss, S.; Bruchez, M.J.; Alivisatos, P. Organo Luminescent Semiconductor Nanocrystal Probes for Biological Applications and Process for Making and Using Such Probes. U.S. Patent 2006/003464, 5 January 2006.
33. Chen, F.F.; Gerion, D.; Gray, J.W.; Budinger, T.F. Multimodal Imaging Probes for in Vivo Targeted and Non-targeted Imaging and Therapeutics. WO/2009/045579, 9 April 2009.
34. Chen, F.F.; Bouchard, L. Multi-modality Nanoparticles Having Optically Responsive Shape. WO/2010/096828, 26 August 2010.
35. Van Bommel, T.; Willard, N.P. Ultrasound Contrast Agents for Molecular Imaging. WO/2005/070473, 4 August 2005.
36. Willard, N.P.; Van Bommel, T. Ultrasound Contrast Agents for Molecular Imaging. WO/2006/054240, 26 May 2006.
37. Gao, J.; Hillebrenner, H.L. Nanotubular Probes as Ultrasensitive MR Contrast Agent. U.S. Patent 2008/124281, 29 May 2008.
38. Yuan, Z.; Seo, S. Methods and Compositions for Nanoparticle-Mediated Cancer Cell-Targeted Delivery. WO/2011/088456, 21 July 2011.
39. Sung, H.; TU, H. Nanoparticles for Protein Drug Delivery. U.S. Patent 7863259, 4 January 2011.
40. JIN, S.; OH, S. Articles Comprising Large-Surface-Area Bio-Compatible Materials and Methods for Making and Using Them. WO/2008/066965, 5 June 2008.
41. Zhang, L.; Aryal, S.; Hu, C. Ratiometric Combinatorial Drug Delivery. WO/2011/143201, 17 November 2011.
42. Zugates, G.T.; Zumbuehl, A.; Langer, R.S.; Anderson, D.G. End-Modified Poly(beta-amino esters) and Uses Thereof. WO/2008/011561, 24 January 2008.
43. Alexis, F.; Zhang, L.; Radovic-Moreno, A.F.; Gu, F.X.; Basto, P.; Levy-Nissenbaum, E.; Chan, J.; Langer, R.S.; Farokhzad, O.C. Poly(amino acid) Targeting Moieties. WO/2008/124639, 16 October 2008.
44. Von Andrian, U.H.; Farokhzad, O.C.; Langer, R.S.; Junt, T.; Moseman, A.; Zhang, L.; Basto, P.; Iannacone, M.; Alexis, F. Vaccine Nanotechnology. WO/2009/051837, 23 April 2009.
45. Von Maltzahn, G.A.; Bhatia, S.N. Methods and Systems for Treatment and/or Diagnosis. WO/2010/101627, 10 Sepetember 2010.
46. Farokhzad, O.C.; Salvador-Morales, C.; Gao, W.; Zhang, L.; Chen, J.M.; Langer, R.S. Particles with Multiple Functionalized Surface Domains. WO/2010/042555, 15 April 2010.
47. Lam, K.S.; Liu, R; Peng, L. Alpha-4 Beta-1 Integrin Ligands for Imaging and Therapy. U.S. Patent 2006/019900, 26 January 2006.
48. Guo, T. Nanoparticle Radiosensitizers. WO/2006/037081, 6 April 2006.